| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |